| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/19/2003 | CN1457339A Chemokine receptor binding heterocyclic compounds |
| 11/19/2003 | CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 11/19/2003 | CN1457261A Method and compositions for prevention or treatment of cancer |
| 11/19/2003 | CN1457258A Methods of treating viral diseases with IL-18 and IL-18 compositions |
| 11/19/2003 | CN1457256A Eye drops |
| 11/19/2003 | CN1457255A Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use |
| 11/19/2003 | CN1457253A External application for enhancing skin permeability of active components therein |
| 11/19/2003 | CN1456574A Preparing method for extracting polypeptide antibiotics from silkworm |
| 11/19/2003 | CN1456568A Organic salts of parabuxinidine-D, their preparations and uses |
| 11/19/2003 | CN1456561A Preparations of leucovorin and its carbonates |
| 11/19/2003 | CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines |
| 11/19/2003 | CN1456556A Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 11/19/2003 | CN1456548A Process for extracting leonuridine from fresh motherwort and leonuridine preparation |
| 11/19/2003 | CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
| 11/19/2003 | CN1456336A Rhodiola root powdery injection and its preparation |
| 11/19/2003 | CN1456333A Capsules against thrombus and preparation thereof |
| 11/19/2003 | CN1456276A Medicines for treating thyroma and hydatoncus |
| 11/19/2003 | CN1456275A Medicines for treating Hashimoto's thyroncus |
| 11/19/2003 | CN1456274A Medicine for treating endocrine infiltrative exophthalmos |
| 11/19/2003 | CN1456178A External applied medicine for curing burn and preparing method thereof |
| 11/19/2003 | CN1456172A Healthy vitamin nutrient solution |
| 11/19/2003 | CN1456170A External applied medicine composition containing vitamin š�* |
| 11/19/2003 | CN1456169A Preparation with haw leaf extractive as main effect composition |
| 11/19/2003 | CN1456168A Anti-fatigue formulating prescription |
| 11/19/2003 | CN1456167A Artificial tear containing phosphatide and preparing method thereof |
| 11/19/2003 | CN1456166A Instant biliary ascariasis preparation |
| 11/19/2003 | CN1456165A Method for increasing solubility of parabuxinidine-D injection |
| 11/19/2003 | CN1456164A Parabuxinidine pills and preparation thereof |
| 11/19/2003 | CN1456163A Oral medicine of leucovocin calcium and its preparing method |
| 11/19/2003 | CN1456162A Injection of leucovorin calcium and its preparing method |
| 11/19/2003 | CN1456161A Eye gel for atropine sulfate |
| 11/19/2003 | CN1456160A Preparation of composite motidine dispersant pills |
| 11/19/2003 | CN1456159A Fluconazole injection and its preparing process |
| 11/19/2003 | CN1456158A Eye drops of fluconazole |
| 11/19/2003 | CN1456157A Ophthalmic gel of L-ofloxacin |
| 11/19/2003 | CN1456156A Ophthalmic gel of marticarpine |
| 11/19/2003 | CN1456155A Mesilate phentolamine suppository and its preparation |
| 11/19/2003 | CN1456154A Method for curing sepsis |
| 11/19/2003 | CN1456153A Preparing method for Xiatianwu alkaloids |
| 11/19/2003 | CN1456152A Lyophilized preparation of civeleth sodium |
| 11/19/2003 | CN1456151A Preparing method for sustained releasing huperzine preparation |
| 11/19/2003 | CN1456150A Garlicin injection preparation |
| 11/19/2003 | CN1456148A Use of enlerogastric dynamic medicine in preparation of colonic orientation medicinal composition |
| 11/19/2003 | CN1128224C Process for production of lipstation and tetraphydrolipstatin |
| 11/19/2003 | CN1128223C Production process of compound L-amino acid calcium |
| 11/19/2003 | CN1128149C 6,9-disubsituted 2-[trans-(4-aminocyclohexyl)amino]purines |
| 11/19/2003 | CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors |
| 11/19/2003 | CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same |
| 11/19/2003 | CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same |
| 11/19/2003 | CN1128139C New piperazine derivatives and its prepn. |
| 11/19/2003 | CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative |
| 11/19/2003 | CN1127976C Exterior-applied Chinese-medicinal pill for treatnig diarrhea |
| 11/19/2003 | CN1127970C Ointment for treating burn and its preparing process |
| 11/19/2003 | CN1127966C 'Hehe' ointment and its preparing process |
| 11/19/2003 | CN1127961C Exterior-applied medicine for treatnig dermatopathy and its preparing process |
| 11/19/2003 | CN1127960C Eyesight improving medicine liquid |
| 11/19/2003 | CN1127959C Application of isopropylfuran in preparing hepatitis B virus resisting medicine |
| 11/19/2003 | CN1127958C Use of baicalin flavone in treating depression |
| 11/19/2003 | CN1127957C Exterior-applied medicine for treating chilblains |
| 11/19/2003 | CN1127956C Medicine for curing and operating purpose and its preparing method |
| 11/19/2003 | CN1127955C Medicine for treating immune relative disease of anterior chamber and surface of eye |
| 11/19/2003 | CN1127954C Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol for treatment of sleep disorders |
| 11/19/2003 | CN1127953C Medicine for delaying chronic kidney hypofunction |
| 11/19/2003 | CN1127952C Anticancer medicine composition |
| 11/19/2003 | CN1127951C Application of rhein in treating insulin resistance |
| 11/19/2003 | CN1127950C Antirheumatic agents |
| 11/19/2003 | CN1127949C Composite coenzyme Q10 health nutriment |
| 11/18/2003 | US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition |
| 11/18/2003 | US6649797 Contacting protein with a compound that is capable of stable reversible binding with basic amino acid residues of nuclear localization signal of protein for inactivating a nuclear localization signal of a protein |
| 11/18/2003 | US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 11/18/2003 | US6649762 Crystal modification C of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihyro-4-oxo-3-quinoline carboxylic |
| 11/18/2003 | US6649756 Process improvement in the preparation of (4r, 5s, 6s)-3-[[(2r,3r)-2-[[[(s)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
| 11/18/2003 | US6649755 Process for preparing acarbose with high purity |
| 11/18/2003 | US6649747 Composition and method for diagnosing auto-immune hepatitis |
| 11/18/2003 | US6649745 Oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanoside |
| 11/18/2003 | US6649660 Composition for treatment of infections of humans and animals |
| 11/18/2003 | US6649659 Atovaquone pharmaceutical compositions |
| 11/18/2003 | US6649658 (−)-Verbenone derivatives |
| 11/18/2003 | US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 11/18/2003 | US6649655 11β-fluoro 15β-hydroxy PGF2α analogs as FP receptor antagonists |
| 11/18/2003 | US6649654 Methods for identifying and using IKK inhibitors |
| 11/18/2003 | US6649653 15-fluoro prostaglandins as ocular hypotensives |
| 11/18/2003 | US6649652 Prodrugs for antimicrobial amidines |
| 11/18/2003 | US6649651 AIDS; human T-cell lymphoma/leukemia virus or lymphadenopathy associated virus treatment |
| 11/18/2003 | US6649650 Herbal chemical composition for the treatment of cancer |
| 11/18/2003 | US6649649 Method of treating colonic adenomas |
| 11/18/2003 | US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent |
| 11/18/2003 | US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
| 11/18/2003 | US6649644 Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor |
| 11/18/2003 | US6649641 Glucagon antagonists/inverse agonists |
| 11/18/2003 | US6649640 Isoxazole compositions useful as inhibitors of ERK |
| 11/18/2003 | US6649639 Inhibit or block the biological activity of the picornaviral 3C protease. |
| 11/18/2003 | US6649637 Inhibiting intracellular replication of a parasite that possesses endogenous mitogen activated protein parasite that possesses endogenous mitogen activated protein kinase activity, by contact with a substituted imidazole |
| 11/18/2003 | US6649636 Cyclooxygenase inhibitors |
| 11/18/2003 | US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals |
| 11/18/2003 | US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 11/18/2003 | US6649631 Administering pyridine derivative |
| 11/18/2003 | US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 11/18/2003 | US6649628 Retinopathy, neuropathy and nephropathy treatment; antidiabetic agents |
| 11/18/2003 | US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea |